Lectin Assay for Assessing Glycoforms as an Early Marker in Disease
    2.
    发明申请
    Lectin Assay for Assessing Glycoforms as an Early Marker in Disease 审中-公开
    用于评估糖酵解作为疾病早期标记物的凝集素测定

    公开(公告)号:US20150198610A9

    公开(公告)日:2015-07-16

    申请号:US13388971

    申请日:2012-02-03

    摘要: The present invention provides methods, compositions, apparatus, and kits for assessing glycoforms of proteins as a biomarker for disease. A purified recombinant form of lectin is used as a detector molecule to specifically label target sugars expressed in disease states. The high affinity of recombinant lectin allows for automation of assays that would be used in the diagnosis of diseases such as, but not limited to, cancer or liver disease.

    摘要翻译: 本发明提供了用于评估蛋白质糖蛋白作为疾病生物标志物的方法,组合物,装置和试剂盒。 使用纯化的重组形式的凝集素作为检测分子来特异性标记在疾病状态中表达的目标糖。 重组凝集素的高亲和力允许自动化将用于诊断疾病例如但不限于癌症或肝脏疾病的测定。